Campaign against aspirin?

For decades, a daily regimen of low-dose so-called “baby aspirin” (81milligrams), was recommended to prevent and treat heart attack, stroke and angina (chest pain) in those 50 and older
 

That began to change in 2014, when the U.S. Food and Drug Administration started warning against the use of aspirin as a primary preventive for these conditions. In late 2021, the United States Preventive Services Task Force (USPSTF) also updated its guidance to formally discourage people 60 and older from using an aspirin regimen to prevent a first heart attack or stroke
 

Aspirin is likely the victim of an intentional pharma discrediting campaign to justify and promote the use of newer, patented and far more expensive nonsteroidal anti- inflammatory drugs (NSAIDs) and anticoagulants

Research has shown aspirin works just as well as pricier anticoagulants such as heparin and Xarelto for preventing post-operative blood clots and clots associated with bone fractures
 

Aspirin also increases the oxidation of glucose as fuel, and has anti-lipolytic effects, so it helps lower both the supply of dangerous omega-6 fat to your cells and the excessive oxidation of fats. Aspirin will also lower your baseline cortisol, indirectly by lowering inflammation, and directly by inhibiting the enzyme that synthesizes active cortisol from the inactive precursor cortisone

Read the full analysis by Dr. Mercola
 

 
Subscribe to Mercola for more news & videos